9. Montillo M,Mirto S,Pierri I,et al. fludarabine ,cytarabine and G-CSF(FLAG) for the treatment of poor risk acute myeloid leukemia .Am J Hematol,1998,58:105-109
Fludarabine, cytarabine and G-CSF (FLAG) for the treatment of acute myeloid leukemia relapsing after autologous stem cell transplantation. Ann Hematol 1999;78:380-4.Fludarabine, cytarabine, and G-CSF (FLAG) for the treatment of acute myeloid leukemia relapsing after autologous stem cell ...
Twenty-six patients affected by acute myeloid leukemia (AML) who relapsed after autologous stem cell transplantation (ASCT) were treated with the FLAG regimen (fludarabine, cytarabine, and G-CSF). Their median age was 39 years (range 14-59). The median interval from achievement of CR to ASCT...
FLAG方案治疗难治性急性髓细胞性白血病的回顾性分析 英文缩写词表 英文缩写英文全称 AMe CR PR NP AML AMML AL 中文全称 acute myeloid leukemia急性髓细胞性白血病 complete remission完全缓解 partly remission部分缓解 nOremISSlon无缓解 acute myeloblastic leukemia急性粒细胞白血病 acute myelo—monocytic leukemia急性...
( 1994 ) FLAG (fludarabine + high-dose cytarabine + G-CSF): an effective and tolerable protocol for the treatment of ‘poor risk’ acute myeloid ... G Visani,P Tosi,PL Zinzani,... - 《Leukemia》 被引量: 266发表: 1994年 Fludarabine, cytarabine, G-CSF and idarubicin (FLAG-IDA) for...
5、onclusions: FLAG program is a better choice for relapse or refractory patients with acute myelogenous leukemia. KEY WORDS Acute myeloid leukemia; Relapse; Refractory; Fludarabine 复发或难治性急性髓系白血病(acute myeloid leukemia, AML)患者疗效不佳,预后差。氟达拉滨(Flu)属氟化嘌呤类似物免疫抑制...
FLAG和MEA方案治疗难治复发性急性髓系白血病的Meta分析
Fludarabine, cytarabine, and G-CSF (FLAG) for the treatment of acute myeloid leukemia relapsing after autologous stem cell transplantation Twenty-six patients affected by acute myeloid leukemia (AML) who relapsed after autologous stem cell transplantation (ASCT) were treated with the FLAG regi... F...
Objective To investigate the efficacy and diverse effect of FLAG regimen in the treatment of relapsed/refractory acut... 关键词 leukemia/drug therapy / acute disease / vidarabine/administration & dosage / antineoplastic combined chemother...
Conclusio: FLAG program is a better choice for relapse or refractory patients with acute myelogenous leukemia. [KEY WORDS] Acute myeloid leukemia; Relapse; Refractory; Fludarabine 复发或难治性急性髓系白血病(acute myeloid leukemia, AML)患者疗效不佳,预后差。氟达拉滨(Flu)属氟化嘌呤类似物免疫抑制剂,...